LensAR laser cataract surgery system receives FDA approval for anterior capsulotomy, laser phacofragmentation

LensAR (Orlando, FL) has received FDA approval of its next-generation LensAR Laser System for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery. While the company’s first-generation platform had received FDA clearances already, this FDA approval covers the version that is now in final preparation for commercial launch in the U.S.

The system's proprietary technology for 3D imaging measurement and beam-guided delivery generates a personalized surgical treatment plan: Precise measurement of lens tilt and decentration in 3D aligns the treatment plan with the patient’s unique positioning, anatomy, and visual axis. Cataract fragmentation cutting algorithms address all cataract grades, while reducing or eliminating the amount of ultrasound energy required to complete the surgery. Also, the system features a laser head and patient docking system that moves to the patient while accommodating a standard patient gurney.

So far, commercial LensAR Laser Systems have been installed at the Instituto de Ojos Sacro Cuore (Lima, Peru) and the Asian Eye Institute (The Philippines).


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow Laser Focus World on your iPhone or Android

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World